EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Evaluating the Therapeutic Potential of Ublituximab in the Treatment of MS: Design, Development and Place in Therapy

Sarah-Jane Martin iD, Melanie Guenette, Jiwon Oh

Drug Design, Development and Therapy · 2024-07 · Volume 18 · 3025-3042

DOI: 10.2147/dddt.s388410 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2024-07. Verfasst von Sarah-Jane Martin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Department of Medicine, St Michael's Hospital, Toronto, Canada. Hauptthemen laut MEDLINE: Multiple Sclerosis, Antibodies, Monoclonal. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisAntibodies, MonoclonalHumansDrug DevelopmentAntigens, CD20Drug DesignB-LymphocytesAnimals

Stichwörter der Autor:innen

B-cell therapyanti-CD20 monoclonal antibodymultiple sclerosisublituximab

Substanzen

Antibodies, MonoclonalublituximabAntigens, CD20

Autor:innen und Institutionen

  • Division of Neurology, Department of Medicine, St Michael's Hospital, Toronto, Canada.
  • University of Glasgow, Glasgow, UK.

ORCID-Profile: Sarah-Jane Martin

Zitieren

APA

Martin, S. J., Guenette, M., & Oh, J. (2024). Evaluating the Therapeutic Potential of Ublituximab in the Treatment of MS: Design, Development and Place in Therapy. Drug Design, Development and Therapy, Volume 18, 3025-3042. https://doi.org/10.2147/dddt.s388410

Vancouver

Martin SJ, Guenette M, Oh J. Evaluating the Therapeutic Potential of Ublituximab in the Treatment of MS: Design, Development and Place in Therapy. Drug Design, Development and Therapy. 2024;Volume 18:3025-3042. doi:10.2147/dddt.s388410

BibTeX
@article{Martin2024,
  author = {Martin, Sarah-Jane and Guenette, Melanie and Oh, Jiwon},
  title = {Evaluating the Therapeutic Potential of Ublituximab in the Treatment of MS: Design, Development and Place in Therapy},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  volume = {Volume 18},
  pages = {3025--3042},
  doi = {10.2147/dddt.s388410}
}
Kostenlos starten →